Mental and Behavioral Disturbances in Dementia: Findings from the Cache County Study on Memory in Aging by Lyketsos, Constantine G. et al.
Article
708 Am J Psychiatry 157:5, May 2000
Mental and Behavioral Disturbances in Dementia: 
Findings From the Cache County Study
on Memory in Aging
Constantine G. Lyketsos, M.D., 
M.H.S.
Martin Steinberg, M.D.
JoAnn T. Tschanz, Ph.D.
Maria C. Norton, M.S.
David C. Steffens, M.D.
John C.S. Breitner, M.D., M.P.H.
DISTURBANCES IN DEMENTIA
LYKETSOS, STEINBERG, TSCHANZ, ET AL.
Objective: The authors report findings
from a study of 5,092 community resi-
dents who constituted 90% of the elderly
resident population of Cache County,
Utah.
Method: The 5,092 participants, who
were 65 years  o ld or  o lder,  were
screened for dementia. Based on the re-
sults of this screen, 1,002 participants
(329 with dementia and 673 without de-
mentia) underwent comprehensive neu-
ropsychiatric examinations and were
rated on the Neuropsychiatric Inventory,
a widely used method for ascertainment
and classification of dementia-associated
mental and behavioral disturbances.
Results: Of the 329 participants with de-
mentia, 214 (65%) had Alzheimer’s dis-
ease, 62 (19%) had vascular dementia,
and 53 (16%) had another DSM-IV de-
mentia diagnosis; 201 (61%) had exhib-
ited one or more mental or behavioral
disturbances in the past month. Apathy
(27%), depression (24%), and agitation/
aggression (24%) were the most com-
mon in participants with dementia.
These disturbances were almost four
times more common in participants
with dementia than in those without.
Only modest differences were observed
in the prevalence of mental or behav-
ioral disturbances in different types of
dementia or at different stages of illness:
participants with Alzheimer’s disease
were more likely to have delusions and
less likely to have depression. Agitation/
aggression and aberrant motor behavior
were more common in participants with
advanced dementia.
Conclusions: On the basis of their find-
ings in this large community population
of elderly people, the authors conclude
that a wide range of dementia-associ-
ated mental and behavioral distur-
bances afflict the majority of individuals
with dementia. Because of their fre-
quency and their adverse effects on pa-
tients and their caregivers, these distur-
bances should be ascertained and
treated in all cases of dementia.
(Am J Psychiatry 2000; 157:708–714)
Dementia is a common and growing public health
problem. The most common causes of dementia are
Alzheimer’s disease and vascular dementia. Both of these
are progressive illnesses that lead to functional complica-
tions, debilitation, and eventually death (1). A serious and
common complication of dementia is the occurrence of
mental and behavioral disturbances (2). Many such dis-
turbances have been described. Their classification has
typically been phenomenological, relying on a description
of mental state and problematic behaviors. The resulting
categories range from “psychotic features” (delusions and
hallucinations), to depressive symptoms, to a series of
other behaviors such as agitation/aggression, wandering,
and disinhibition. Such disturbances are associated with
earlier nursing home referral, worse prognosis, greater
costs, and increased caregiver burden (1, 2).
Several studies have described the frequency of mental
and behavioral disturbances in dementia. Prevalence esti-
mates have varied widely in studies using different meth-
ods, which have suggested that as few as 25% or as many
as 80% of patients with dementia suffer from such distur-
bances (2–4). There is controversy about the prevalence of
different disturbances in patients with different types of
dementia. Some studies (5, 6) suggest that depression is
specifically more common in vascular dementia than in
Alzheimer’s disease. Others (7, 8) disagree. There is also
controversy about the occurrence of these disturbances in
patients with varying severity of dementia (9, 10), al-
though psychotic symptoms seem to be more common in
advanced dementia (11). Almost all relevant studies have
come from clinical populations such as patients in de-
mentia, geriatric, or psychogeriatric clinics or Alzheimer’s
disease research centers. These sources are subject to re-
ferral bias. Estimates from general population samples, al-
though more informative, are rare.
To our knowledge, the only published population-
based study of psychiatric phenomena in dementia (12–
15) relied on ascertainment of patients with Alzheimer’s
disease from a defined area in the United Kingdom. This
important study estimated the prevalence of individual
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mental and behavioral disturbances in 178 individuals
with Alzheimer’s disease and reported the following cu-
mulative prevalences of individual mental and behavioral
disturbances: delusions, 16%; hallucinations, 17%; major
depression, 24%; mania, 3.5%; agitation/aggression, 20%;
wandering, 19%; and apathy, 41%. Because that study fo-
cused on Alzheimer’s disease, it did not make compari-
sons between patients with Alzheimer’s disease and non-
demented patients. It did not investigate other types of
dementia or study the prevalence of various disturbances
at different stages of dementia severity. Also, the study
was conducted in the United Kingdom, leaving open the
possibility that there might be differences in dementia-
associated mental and behavioral disturbances between
the United Kingdom and the United States and other
countries.
Cummings et al. (16) proposed a classification system
and measurement method for dementia-associated men-
tal and behavioral disturbances that used the Neuropsy-
chiatric Inventory. The Neuropsychiatric Inventory distin-
guishes 10 different mental or behavioral disturbances in
dementia. Each operationally defined disturbance is as-
certained by a trained examiner through an interview with
the caregiver. The Neuropsychiatric Inventory is reliable
and valid and has received wide acceptance, as is evi-
denced by its wide use in a variety of studies of dementia.
However, to our knowledge, no population-based study
has used this instrument to investigate mental and behav-
ioral disturbances in dementia.
In this article we report findings from a study of 5,092
participants who constituted 90% of the elderly resident
population of Cache County, Utah. After screening and
careful case ascertainment, we identified 329 participants
with dementia. Thus, we identified a population-based
panel of individuals with dementia who were carefully
characterized clinically. We used the Neuropsychiatric In-
ventory (16) to study all participants with dementia as well
as a comparison group of 673 individuals without demen-
tia. We then estimated the population prevalence of indi-
vidual Neuropsychiatric Inventory mental and behavioral
disturbances in individuals with dementia and in the par-
ticipants without dementia. We compared the prevalence
of dementia-associated mental and behavioral distur-
bances in the two most common types of dementia—
Alzheimer’s disease and vascular dementia—and, finally,
estimated the prevalence of individual disturbances at dif-
ferent stages of dementia severity.
Method
Sampling and Screening
The methods of the Cache County Study of Memory in Aging
are reported in detail elsewhere (17). The sampling method of this
study is outlined in Figure 1. Briefly, we approached all perma-
nent residents of Cache County, Utah, who were 65 years old or
older in January 1995 (N=5,677). We enrolled 5,092 of these indi-
viduals (90%), who were then given the Modified Mini-Mental
State (18). Individuals who could not participate directly were
characterized by the results of an interview with the Informant
Questionnaire on Cognitive Decline in the Elderly (19) conducted
with a knowledgeable informant. Individuals whose screening
scores suggested possible cognitive impairment were studied fur-
ther with the Dementia Questionnaire (20). The Dementia Ques-
tionnaire was also used to study a stratified probability sample of
the entire population (the subsample in Figure 1), irrespective of
results on the Modified Mini-Mental State or the Informant Ques-
tionnaire on Cognitive Decline in the Elderly. The subsample, and
all other participants with a Dementia Questionnaire rating of 4
(suspected dementia) or 5 (probable dementia), underwent a
comprehensive clinical assessment in the presence of a collateral
informant at their place of residence (including nursing homes).
The study was approved by the institutional review boards of
Duke University Medical Center, the Johns Hopkins School of
Public Health, and Utah State University. All study participants or
their next of kin signed an informed consent document for each
stage of assessment.
Participant Assessment, Diagnosis, 
and Staging of Dementia
A research nurse and a psychometric technician conducted the
comprehensive evaluations, along with a board-certified geriatric
psychiatrist (D.C.S. or J.C.S.B.). The geriatric psychiatrist directly
evaluated 236 participants. Evaluations included history, mental
status examination, standardized neurological examination, brief
physical examination, and a 1-hour neuropsychological battery.
In addition, we reviewed medical records when relevant and re-
FIGURE 1. Sampling Method in a Community Study of De-
mentia Among Elderly People in Cache County, Utah
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quested laboratory tests for participants with dementia, includ-
ing CBC, chemistries, B12, folic acid, thyroid function tests, and
urinalysis, when these tests had not been conducted in the last 6
months. Brain magnetic resonance images or, rarely and only
when indicated, computerized tomography scans were also ob-
tained for the majority of participants with dementia. Results of
laboratory studies and brain imaging were used in final diagnos-
tic formulations.
We used data from these evaluations to classify study partici-
pants into groups of participants who were evidently suffering
from dementia or not and into distinct clinical diagnostic catego-
ries. These assignments were made at initial diagnostic confer-
ences that included the staff who conducted the evaluation and a
board-certified geriatric psychiatrist (D.C.S. or J.C.S.B.). Cases of
participants with an initial diagnosis of dementia were then re-
viewed for final diagnosis at a conference that included the two
geriatric psychiatrists, a board-certified neurologist, a senior neu-
ropsychologist, and a cognitive neuroscientist.
Of 1,033 participants examined, 335 (32%) were diagnosed
with dementia. Of these, 329 were rated on the Neuropsychiatric
Inventory, along with 673 participants without dementia—the
rest refused or could not be rated. The 329 participants with de-
mentia who were rated on the Neuropsychiatric Inventory were
further classified at the adjudication conference as to their type of
dementia. On the basis of the criteria of the National Institute of
Neurological and Communicative Disorders and Stroke and the
Alzheimer’s Disease and Related Disorders Association, 214 were
diagnosed with probable or possible Alzheimer’s disease. Accord-
ing to Association Internationale pour la Recherche et l’Enseigne-
ment en Neurosciences criteria, 62 were diagnosed with probable
or possible vascular dementia. An additional 53 received a DSM-
IV diagnosis of dementia but did not meet the criteria for Alzhei-
mer’s disease or vascular dementia; 32 of these participants were
diagnosed with dementia of unknown etiology, four with fronto-
temporal dementia, four with hypoperfusion dementia, four with
Lewy body dementia, three with alcohol-related dementia, and
two each with posttraumatic dementia, normal-pressure hydro-
cephalus, or Pick’s disease.
Study participants with dementia were also classified by stage
or severity of dementia by using the Clinical Dementia Rating
(21), a broadly used method for rating stages of dementia. Of the
329 participants with dementia who were rated on the Neuropsy-
chiatric Inventory, 134 were at Clinical Dementia Rating stages
0.5 or 1, 90 were at stage 2, and 105 were at stages 3–5.
Assessment of Mental and Behavioral Disturbances
The 1,002 participants with and without dementia were given
the Neuropsychiatric Inventory by a trained psychometrician or
nurse. The Neuropsychiatric Inventory is a fully structured infor-
mant interview that specifies verbatim the questions asked. Study
participants were rated as experiencing or not experiencing each
of 10 domains in the past month: delusions, hallucinations, agita-
tion, depression, anxiety, elation, apathy, disinhibition, irritabil-
ity, and aberrant motor behavior (e.g., wandering or pacing).
Within each domain, the Neuropsychiatric Inventory includes a
screening question. The rater is instructed to move to the next do-
main if the screening item is answered in the negative. Otherwise,
the rater asks a series of individual questions describing behavior
reflective of disturbance in that domain. Once the disturbances
relevant to each domain (e.g., delusions) are defined for the infor-
mant, then the informant is asked about the frequency of these
on a 4-point scale from 1 (occasionally) to 4 (very frequently,
more than once a day). The informant is also asked to rate the se-
verity of the behavior on a 3-point severity scale (mild, moderate,
or severe).
Within each Neuropsychiatric Inventory domain, scores of 0 to
4 are possible for the frequency of the disturbance and 0 to 3 for
its severity. The Neuropsychiatric Inventory then yields a domain
rating of frequency times severity (range=0–12). Finally, there is a
total Neuropsychiatric Inventory score that sums the individual
domain scores.
Analyses
Our first goal was to estimate the prevalence and severity of
mental and behavioral disturbances in participants with demen-
tia and compare these with results from nondemented partici-
pants. We compared the proportion of participants with and
without dementia who had a score of 1 or higher in any individual
Neuropsychiatric Inventory domain. (A score of 1 or higher indi-
cates the presence of any disturbance in the domain.) We also
compared Neuropsychiatric Inventory mean scores for partici-
pants with and without dementia as an indicator of global sever-
ity in each domain.
To test the hypothesis that participants with dementia would
experience more Neuropsychiatric Inventory disturbances, we
constructed a series of logistic regression models, one for each
Neuropsychiatric Inventory domain and one for the Neuropsy-
chiatric Inventory as a whole. In these models, the presence or
absence of a nonzero score within a given domain (or on the Neu-
ropsychiatric Inventory as a whole) was the dependent variable
and the presence or absence of dementia was the independent
variable.
To test the hypothesis that participants with dementia had
higher Neuropsychiatric Inventory domain or total scores, we
constructed a series of linear regression models, one for each do-
main and one for the total Neuropsychiatric Inventory score. In-
dividual Neuropsychiatric Inventory domain scores or the Neu-
ropsychiatric Inventory total score were the dependent variables,
and the presence or absence of dementia was again the indepen-
dent variable.
Our other goal was to compare the prevalence of mental and
behavioral disturbances in participants with different types of de-
mentia, especially Alzheimer’s disease and vascular dementia
(the group with other dementias was relatively small [N=53] and
heterogeneous). As before, we used logistic regression to compare
the prevalence of individual disturbances and linear regression to
compare Neuropsychiatric Inventory domain and total scores.
Our final goal was to assess the prevalence and severity of de-
mentia-associated mental and behavioral disturbances across
the different stages of dementia. For this purpose we calculated
the prevalence of different disturbances and the mean Neuropsy-
chiatric Inventory domain (and total) scores for participants with
dementia having different Clinical Dementia Rating ratings
(those with ratings of 0.5 or 1, those with ratings of 2, and those
with ratings of 3–5). We used logistic regression to compare the
prevalence of individual disturbances across the groups with dif-
ferent Clinical Dementia Rating stages, and we used analysis of
variance (ANOVA) to compare Neuropsychiatric Inventory do-
TABLE 1. Demographic Characteristics of Participants With
and Without Dementia in a Community Study of Elderly
People in Cache County, Utah
Characteristic
Participants 
With
Dementia
(N=329)
Participants
Without
Dementia
(N=673) Analysis
Mean SD Mean SD t df p
Age (years) 84.2 7.0 80.8 7.7 7.16 1,000 <0.0001
Education (years) 12.3 2.9 13.2 3.0 5.00 1,000 <0.0001
N % N % χ2 df p
Male gender 123 37 303 45 4.97 1 <0.03
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main and total scores across the three Clinical Dementia Rating
stages.
There was a small amount of missing Neuropsychiatric Inven-
tory data (less than 5%). We note in the tables the number of par-
ticipants for whom data were available for each domain of the
Neuropsychiatric Inventory.
Results
Table 1 shows the demographic characteristics of par-
ticipants with and without dementia. The participants
with dementia were older and less educated, and more of
them were women.
Table 2 compares participants with and without demen-
tia. Among those with dementia, 201 (61%) suffered from
at least one Neuropsychiatric Inventory disturbance, and
105 (32%) scored at least 6 total points on the Neuropsy-
chiatric Inventory, indicating a moderate to severe distur-
bance. The mean Neuropsychiatric Inventory score for
participants with dementia was about 7, almost 10 times
higher than the comparable score for participants without
dementia. The most frequent disturbance reported for
participants with dementia was apathy (27%). Depression
and agitation/aggression were nearly as common, each
reported in 24% of participants with dementia. The least
frequent symptom was elation, reported in only 1%. Neu-
ropsychiatric Inventory domain scores also reflected these
frequencies, with apathy, depression, and agitation/
aggression having the highest mean scores. In every
Neuropsychiatric Inventory domain, both the proportion
of participants with the disturbance and the mean Neu-
ropsychiatric Inventory score were significantly higher in
the participants with dementia than in the participants
without dementia (for all logistic and linear regression
models, p<0.01).
Table 3 compares the prevalence of Neuropsychiatric
Inventory disturbances in participants with Alzheimer’s
disease and those with vascular dementia. In general, the
prevalence of Neuropsychiatric Inventory disturbances
was similar in the two groups (p>0.10 for linear and logis-
tic regression models of either total Neuropsychiatric In-
TABLE 2. Frequency of Individual Neuropsychiatric Inventory Disturbances and Domain and Total Scores in Participants
With and Without Dementia in a Community Study of Elderly People in Cache County, Utaha
Neuropsychiatric Inventory Item
Participants With Dementia (N=329)b Participants Without Dementia (N=673)b
Item Absent Item Present Item Score Item Absent Item Present Item Score
N % N % Mean SD N % N % Mean SD
Domain
Delusions 259 78.7 61 18.5 0.74 2.21 653 97.0 16 2.4 0.08 0.75
Hallucinations 276 83.9 45 13.7 0.39 1.43 668 99.3 4 0.6 0.01 0.10
Depression 249 75.7 78 23.7 1.06 2.55 624 92.7 47 7.0 0.20 1.03
Anxiety 266 80.9 56 17.0 0.64 1.91 628 93.3 38 5.6 0.14 0.85
Apathy 235 71.4 90 27.4 1.63 3.29 650 96.6 21 3.1 0.14 1.01
Irritability 258 78.4 67 20.4 0.78 2.38 640 95.1 30 4.5 0.10 0.64
Elation 325 98.8 3 0.9 0.03 0.39 669 99.4 2 0.3 0.00 0.50
Agitation/aggression 245 74.5 78 23.7 0.99 2.34 652 96.9 19 2.8 0.11 0.84
Disinhibition 294 89.4 30 9.1 0.46 1.91 665 98.8 6 0.9 0.03 0.50
Aberrant motor behavior 275 83.6 47 14.3 0.79 2.38 662 98.4 3 0.4 0.02 0.35
Total 116 35.3 185 56.2 7.11 10.90 551 81.9 106 15.8 0.76 2.89
a Significant differences (p<0.01) between participants with and without dementia in all proportions of participants with the disturbance (linear
regression) and all mean domain and total scores (logistic regression).
b Numbers across columns do not add up to total N and percents do not add up to 100% in some cases because of missing data.
TABLE 3. Frequency of Individual Neuropsychiatric Inventory Disturbances and Domain and Total Scores of Participants
With Alzheimer’s Disease or Vascular Dementia in a Community Study of Elderly People in Cache County, Utah
Neuropsychiatric Inventory Item
Participants With Alzheimer’s Disease (N=214)a Participants With Vascular Dementia (N=62)a
Item Absent Item Present Item Score Item Absent Item Present Item Score
N % N % Mean SD N % N % Mean SD
Domain
Delusionsb 161 75.2 48 22.4 1.30 6.19 54 87.1 5 8.1 0.24 0.98
Hallucinations 180 84.1 28 13.1 0.72 5.86 53 85.5 8 12.9 0.29 0.96
Depressionc 17 7.9 43 20.1 0.78 2.30 41 66.1 20 32.3 2.78 10.80
Anxiety 175 81.8 31 7.9 0.61 1.90 48 77.4 11 17.7 0.57 1.70
Apathy 150 70.1 61 28.5 1.66 3.30 46 74.2 14 22.6 0.43 3.30
Irritability 168 78.5 43 20.1 0.78 2.18 50 80.6 11 17.7 0.41 0.94
Elation 213 99.5 1 0.5 0.01 0.21 60 96.8 1 1.6 0.10 0.79
Agitation/aggression 163 76.2 48 22.4 1.20 6.12 41 66.1 20 32.3 1.10 2.03
Disinhibition 194 90.7 17 7.9 0.38 1.79 54 87.1 7 11.3 0.52 1.80
Aberrant motor behavior 173 80.8 36 16.8 1.02 2.70 56 90.3 5 8.1 0.19 0.76
Total 79 36.9 114 53.3 8.10 14.30 18 29.0 37 59.7 7.70 13.50
a Numbers across columns do not add up to total N and percents do not add up to 100% in some cases because of missing data.
b Participants with Alzheimer’s disease were more likely to have delusions (odds ratio=3.15, 95% confidence interval [CI]=0.19–0.52, χ2=5.36,
df=1, p=0.02).
c Participants with vascular dementia were more likely to have depression (odds ratio=1.93, 95% CI=1.01–3.67, Wald χ2=4.17, df=1, p=0.04).
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ventory scores or domain scores for hallucinations, agita-
tion/aggression, anxiety, apathy, irritability, elation,
disinhibition, and aberrant motor behavior).
There were two differences between Alzheimer’s disease
and vascular dementia in the logistic regression models:
participants with Alzheimer’s disease were more likely to
have delusions, and participants with vascular dementia
were more likely to have depression (Table 3). In linear re-
gression models, participants with vascular dementia had
higher mean scores in the depression domain than partic-
ipants with Alzheimer’s disease (beta=0.145, t=2.42, df=1,
p=0.02). There were no other significant differences in the
comparison of total and domain Neuropsychiatric Inven-
tory mean scores between individuals with vascular de-
mentia and those with Alzheimer’s disease (in all domains,
p>0.07 in linear regression models).
Table 4 shows the prevalence of individual Neuropsy-
chiatric Inventory disturbances by dementia stage, as
classified by the Clinical Dementia Rating. Differences in
the prevalence of individual Neuropsychiatric Inventory
disturbances across levels of severity of dementia were as-
sessed in logistic regression models. Differences in the
prevalence of agitation/aggression (13% in mild demen-
tia, 24% in moderate dementia, and 29% in severe demen-
tia) were statistically significant (Table 4). Differences in
the prevalence of aberrant motor behavior (9% in mild,
17% in moderate, and 19% in severe dementia) were also
statistically significant (Table 4). The differences in preva-
lence of hallucinations across Clinical Dementia Rating
stages (8% in mild, 21% in moderate, and 15% in severe
dementia) fell just short of statistical significance (Table
4). There were no other substantial differences in the prev-
alence of other Neuropsychiatric Inventory disturbances
across Clinical Dementia Rating stages.
In the ANOVA of mean scores within the Neuropsychiat-
ric Inventory domains, only depression showed statisti-
cally significant differences across Clinical Dementia
Rating stages (F=5.86, df=1, 272, p=0.02). Scores in the de-
pression domain increased with severity of dementia.
There were no other significant differences in mean Neu-
ropsychiatric Inventory domain or total scores (p>0.10 for
all other linear and logistic regression models).
Discussion
We report findings on the prevalence and severity of 10
dementia-associated mental and behavioral disturbances
in a population-based panel of elderly participants with
dementia and in a probability sample of elderly partici-
pants without dementia. Because these rates are not sub-
ject to any substantial referral bias, they should represent
direct estimates of the prevalence of these disturbances in
the subject population. The described method of assess-
ing mental and behavioral symptoms is widely considered
to be at or near the state of the art (22). To our knowledge,
these are the first U.S. estimates of the population preva-
lence of these disturbances in individuals with dementia
and the first such estimates worldwide based on the Neu-
ropsychiatric Inventory.
The point prevalence of any Neuropsychiatric Inventory
disturbance was 61%; for any serious disturbance it was
32%. Apathy was the most common disturbance reported,
and depression or agitation/aggression were present in
one out of every four participants. The prevalence of all
disturbances was much higher in participants with de-
mentia than in those without dementia. Estimates for par-
ticipants with Alzheimer’s disease are similar to those re-
ported by Burns et al. (12–15). Thus, the two published
population-based studies of these disturbances in partici-
TABLE 4. Frequency of Neuropsychiatric Inventory Disturbances and Domain and Total Scores of Participants Classified by
Clinical Dementia Rating Stage in a Community Study of Elderly People in Cache County, Utah
Neuropsychiatric
Inventory Item
Clinical Dementia Rating Stage
0.5 or 1.0 (N=134)a 2 (N=90)a 3–5 (N=105)a
Item
Absent
Item 
Present Item Score
Item
Absent
Item
Present Item Score
Item
Absent
Item
Present Item Score
N % N % Mean SD N % N % Mean SD N % N % Mean SD
Domain
Delusions 115 85.9 18 13.4 1.70 7.00 64 71.1 24 26.7 1.20 2.90 80 76.2 20 19.0 0.78 2.25
Hallucinationsb 123 91.8 11 8.2 0.18 0.92 69 76.7 19 21.1 0.79 2.20 84 80.0 16 15.2 1.15 8.40
Depression 103 76.9 31 23.1 0.80 2.00 59 65.6 29 32.2 1.30 2.73 85 81.0 20 19.0 1.78 8.70
Anxiety 112 83.6 20 14.9 0.48 1.60 65 72.2 21 23.3 0.99 2.35 89 84.8 14 13.3 0.46 1.85
Apathy 97 72.4 36 26.9 1.20 2.35 67 74.4 20 22.2 1.10 2.41 70 66.7 34 32.4 2.33 4.10
Irritability 111 82.8 21 15.7 0.41 1.48 66 73.3 21 23.3 0.80 1.74 81 77.1 24 22.9 0.97 2.60
Elation 133 99.3 1 0.7 0.02 0.17 87 96.7 1 1.1 0.07 0.66 105 100.0 1 1.00 0.03 0.31
Agitation/aggressionc 114 85.1 17 12.7 1.00 7.00 64 71.1 22 24.4 0.90 1.80 66 62.3 30 28.6 1.57 3.20
Disinhibition 123 91.8 11 8.2 0.30 1.34 79 87.8 8 8.9 0.50 1.98 92 86.8 12 11.4 0.47 1.90
Aberrant motor 
behaviord 119 88.9 12 9.0 0.28 0.91 72 80.0 15 16.7 1.17 3.00 84 79.2 20 19.0 1.10 2.97
Total 58 43.3 65 48.6 5.80 12.50 26 28.9 56 62.2 8.80 11.10 31 29.2 63 60.0 10.6 17.00
a Numbers across columns do not add up to total N and percents do not add up to 100% in some cases because of missing data.
b Nearly significant difference in prevalence between groups (logistic regression beta=0.35, Wald χ2=3.39, df=1, p=0.07).
c Significant difference in prevalence between groups (logistic regression beta=0.69, Wald χ2=18.5, df=1, p<0.0001).
d Significant difference in prevalence between groups (logistic regression beta=0.37, Wald χ2=4.12, df=1, p=0.04).
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pants with dementia agree on the frequency of individual
disturbances. The comparison of participants with Alzhei-
mer’s disease and vascular dementia yielded few consis-
tent differences, a finding that has been observed else-
where (5–8). Given that the estimates here are cross-
sectional and considered only over the previous month,
they are probably underestimates of the cumulative prev-
alence of these disturbances over the course of a dement-
ing illness, which may approach 70%–80% (2, 4).
Our results lend modest support to previous reports of
higher rates of depression in vascular dementia (5, 6).
They also suggest that delusions may be more common in
Alzheimer’s disease. These differences in the frequency of
individual disturbances may reflect differences in the
brain regions involved or the pathophysiology of Alzhei-
mer’s disease and vascular dementia. Thus, vascular de-
mentia, which is more likely to affect subcortical areas
widely believed to be involved in mood disorders (23), is
more closely associated with depression. In contrast,
Alzheimer’s disease, which damages temporal lobe areas
often associated with psychosis (24, 25), is more closely as-
sociated with delusions.
Differences in the prevalence of Neuropsychiatric In-
ventory disturbances across stages of dementia severity
are of similar interest. In general, the differences observed
were few and inconsistent. Several disturbances (delu-
sions, anxiety, apathy, irritability, elation, and disinhibi-
tion) were reported with similar severity at all stages of de-
mentia. By contrast, aggression/agitation and aberrant
motor behavior were more common at later stages. The
latter finding may reflect progressive disturbance in the
control of behavior accompanying the advancing brain
damage of dementing diseases. Our findings of increased
occurrence of depression and hallucinations in moder-
ately severe dementia were relatively weak but are consis-
tent with previous reports (6, 9, 10).
The brain areas involved in Alzheimer’s disease and
other dementias are heterogeneous. This gives rise to dis-
tinct clinical pictures, with substantial interpatient vari-
ability, including mental and behavioral disturbances.
Many of these disturbances probably arise from the un-
derlying disease affecting critical brain areas. For example,
studies have shown that depression in Alzheimer’s disease
is associated with damage to the locus ceruleus (26–28)
and that aggression is associated with damage to the sero-
tonergic centers of the brain (29) or with relative preserva-
tion of dopaminergic areas (30). Further careful investiga-
tion of brain/behavior relationships in dementia should
reveal more such relationships, many involving damage to
the limbic system, frontal lobes, or critical neurotransmit-
ter systems.
A few study limitations require discussion. First, al-
though this was an epidemiologic study, it sampled a pop-
ulation that may not be representative of others. The
Cache County population is older and less ethnically di-
verse than the rest of the United States. It has higher rates
of religious affiliation and lower rates of alcoholism and
substance use than elsewhere (17). The comparability of
these findings with those of Burns et al. (12–15) in the
United Kingdom are somewhat reassuring in this regard.
Second, the principal method of assessment of mental
and behavioral disturbances relied on informants and not
on direct examinations of participants. Again, however, we
note that this method generated estimates similar to those
of Burns et al. (12–15), who used psychiatric assessment.
Also, the limitations of the Neuropsychiatric Inventory
method should not apply to comparisons of Neuropsychi-
atric Inventory findings within our study population.
We conclude that mental and behavioral disturbances
are a central component of dementia, regardless of cause
and regardless of stage. Although the dementia syndrome
is defined by its core cognitive features, it seems clear that
almost all individuals with dementia will exhibit mental or
behavioral disturbances at some point in their illness.
These disturbances add substantially to the morbidity and
disability of their illness and to its burden on their caregiv-
ers (4); therefore, it is unrealistic to tackle the problem of
dementia without careful attention to these disturbances.
Experience from general psychiatric practice seems to
suggest an approach to the treatment of most mental and
behavioral disturbances, but there are few intervention
studies and clinical trials of methods for their treatment
(26–34). Most of these studies have focused on symptom
reduction, have been short-term, or have studied single
pharmacological interventions. Thus, there is a critical
need for research that explores more complex interven-
tions (e.g., combinations of pharmacological and other
strategies) and focuses on a broader range of outcomes
(e.g., disability, nursing home admission, and caregiver
burden). Clinicians in all settings, particularly those in pri-
mary care, where most dementia care is practiced, should
pay increased attention to the identification and treat-
ment of these disturbances in their patients.
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